GLP‐1 receptor agonists penetrate the BBB and activate GLP‐1 receptors in the brain.54, 64 However, no T2DM patients developed depression among those using a GLP‐1 receptor agonist in the present study. Here, GLP1R is linked to depressive symptom measurement.